Véronique Baud

Véronique Baud is a Research Director at the INSERM (National Institute for Health and Medical Research), and head of the team "NF-κB, Differentiation and Cancer" at the University Paris Descartes, Paris, France. Her group works at the interface between signal transduction and cancer with a focus on the RelB NF-κB subunit, how it is regulated, and its contributions towards tumour development and resistance to conventional cancer therapies.

Véronique Imbert

Véronique Imbert is a senior researcher at the Mediterranean Center for Molecular Medicine (C3M) in Nice, France. During her thesis she discovered a new mechanism of NF-κB activation dependent of IkBa tyrosine phosphorylation. She is currently working in the team of Dr JF Peyron “Leukemia: Molecular Addictions, Resistances & Leukemic Stem Cells ». Using a PTEN knock out mouse T lymphoma model, she is studying the supportive role of NF-κB in leukemogenesis.

Jean-François Peyron

Jean-François Peyron is a research director at INSERM, head of the team: “Leukemia: Molecular addictions, Resistances & Leukemic Stem Cells“ at the Mediterranean Center for Molecular Medicine (C3M-U1065) in Nice, France. His team is dedicated to understand the pathological mechanisms driving leukemogenesis in order to identify new molecular targets and active molecules for innovative therapeutical strategies: “Kill Leukemia“. Current arreas of research are: metabolism reprogramming, NF-κB and Leukemic Stem Cells.

Gilles Courtois

Gilles Courtoisis is INSERM (National Institute for Health and Medical Research) Research Director working at CEA Grenoble, Grenoble, France. He studies regulators of the NF-κB activation process and how they impact on human health when mutated in inherited diseases.